University of Perugia
Perugia, 06100, Italy
NCT Number: NCT00222638
The purpose of this study is to evaluate INR and INR related index and Warfarin weekly dosage variations after Influenza Vaccination
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Perugia, 06100, Italy
The pharmacokinetic and the pharmacodynamic interactions and the possible clinical events connected with the simultaneous administration of Oral Anticoagulants (OA) and the influenza virus vaccine were evaluated in several small studies which yielded conflicting results, thus encouraging additional investigations with prospective studies in order to obtain a more consistent evidence about the safety and efficacy of vaccination against influenza virus in patients on OA Treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Of Perugia
Other
Randomized Blinded Cross-Over Clinical Trial Investigate the Interactions Between Influenza Vaccination and Oral Anticoagulant Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05710562
Anticoagulants, Arrhythmias, Cardiac
San Donato Milanese, MI, Italy
View Trial DetailsNCT05065502
Anticoagulants, Dyssomnias
Ann Arbor, Michigan, United States
View Trial DetailsNCT04724460
Anticoagulants, Cardiovascular Diseases
Kyoto, Japan
View Trial DetailsNCT06203795
Anticoagulants, Hemodialysis Complication
Ghent, Belgium
View Trial Details